| Companies sponsors |
Boehringer Ingelheim Ltd (spesolimab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Psoriasis and Psoriatic Arthritis Alliance |
| |
Psoriasis Association |
| Professional groups |
British Association of Dermatologists |
| |
Royal College of Physicians |
| Comparator companies |
AbbVie (adalimumab, risankizumab)(CAU signed - participating) |
| |
Accord Healthcare (methotrexate)(CAU not signed - not participating) |
| |
Advanz Pharma (methotrexate)(CAU not signed - not participating) |
| |
Almirall (dimethyl fumarate, tildrakizumab)(CAU not signed - not participating) |
| |
Amgen (adalimumab, apremilast)(CAU not signed - not participating) |
| |
Aspire Pharma (dimethyl fumarate)(CAU not signed - not participating) |
| |
Biogen Idec (adalimumab, dimethyl fumarate, etanercept, infliximab)(CAU not signed - not participating) |
| |
Bristol Myers Squibb (deucravacitinib)(CAU not signed - not participating) |
| |
B&S Colorama (ciclosporin)(CAU not signed - not participating) |
| |
Celltrion Healthcare UK (adalimumab, infliximab)(CAU not signed - not participating) |
| |
Celix Pharma (dimethyl fumarate)(CAU not signed - not participating) |
| |
Dexcel-Pharma (ciclosporin)(CAU not signed - not participating) |
| |
Eli Lilly and Company (ixekizumab)(CAU not signed - not participating) |
| |
Fresenius Kabi (adalimumab)(CAU not signed - not participating) |
| |
Genus Pharmaceuticals (acitretin, dimethyl fumarate)(CAU not signed - not participating) |
| |
Hospira UK (methotrexate)(CAU not signed - not participating) |
| |
Johnson & Johnson Innovative Medicine (guselkumab, ustekinumab) (CAU signed - participating) |
| |
Leo Pharma (brodalumab) (CAU not signed - not participating) |
| |
Medac GmbH (methotrexate)(CAU not signed - not participating) |
| |
Merck Sharp & Dohme (infliximab)(CAU signed - participating) |
| |
Morningside Healthcare (acitretin, ciclosporin, methotrexate)(CAU not signed - not participating) |
| |
Mylan (ciclosporin, dimethyl fumarate)(CAU not signed - not participating) |
| |
Nordic Pharma (methotrexate)(CAU not signed - not participating) |
| |
Novartis Pharmaceuticals UK (ciclosporin, secukinumab) (CAU signed - participating) |
| |
Orion Pharma (UK) (methotrexate)(CAU not signed - not participating) |
| |
Pfizer (etanercept, infliximab, methotrexate)(CAU not signed - not participating) |
| |
Rosemont Pharmaceuticals (methotrexate)(CAU not signed - not participating) |
| |
Sandoz (adalimumab, etanercept, infliximab, methotrexate)(CAU not signed - not participating) |
| |
Santen UK (ciclosporin)(CAU not signed - not participating) |
| |
Teva UK (acitretin, ciclosporin, methotrexate)(CAU not signed - not participating) |
| |
Therakind Limited (methotrexate)(CAU not signed - not participating) |
| |
UCB Pharma (bimekizumab, certolizumab pegol)(CAU signed - participating) |
| |
Viatris (ciclosporin)(CAU not signed - not participating) |
| |
Wockhardt (dimethyl fumarate)(CAU not signed - not participating) |
| |
Zentiva (dimethyl fumarate) (CAU not signed - not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |